Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUS, SUBCUTANEOUSStandard

ENOXAPARIN SODIUM

ENOXAPARIN SODIUM

Standard Dose
300MG/3ML (100MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ENOXAPARIN SODIUM is listed in Drugs@FDA under application 214856 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ENOXAPARIN SODIUM Form and strength INJECTABLE;INTRAVENOUS, SUBCUTANEOUS - 300MG/3ML (100MG/ML) Sponsor EMERGE BIOSCIENCE Submission history Latest submission status date: 2022-06-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview ENOXAPARIN SODIUM is listed in Drugs@FDA under application 214856 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ENOXAPARIN SODIUM Form and strength INJECTABLE;INTRAVENOUS, SUBCUTANEOUS - 300MG/3ML (100MG/ML) Sponsor EMERGE BIOSCIENCE Submission history Latest submission status date: 2022-06-14 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.